Resveratrol (3,4′,5-trans-trihydroxystilbene), a precursor to pinostilbene (3,4′-dihydroxy-5-methoxystilbene), has been shown to have anticancer activity against prostate cancer and to inhibit transcription activity of AR as well as its protein expression51. This evidence concerns the gene AR and prostate cancer.